Review Article
Volume 8 Issue 11 - 2021
The Role of the Gut Microbiome in Defense against COVID-19
Igor E Khoroshilov*
Professor, Department of Anaesthesiology and Reanimatology Named After V. L. Vanevsky, Federal Public Budget Institution of Higher Education “North-Western State Medical University n. a. I. I. Mechnikov” of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russia
*Corresponding Author: Igor E Khoroshilov, Professor, Department of Anaesthesiology and Reanimatology Named After V. L. Vanevsky, Federal Public Budget Institution of Higher Education “North-Western State Medical University n. a. I. I. Mechnikov” of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russia.
Received: September 02, 2021; Published: October 29, 2021




Abstract

The new coronavirus infection COVID-19, caused by the SARS-CoV-2 virus, was initially described as a “severe acute respiratory syndrome” leading to the development of fatal pneumonia. Later it was shown that the tropism of SARS-CoV-2 to the gastrointestinal epithelial cells is 100 times higher than in the respiratory tract, especially in the ileum. It has been established that although SARS-CoV-2 RNA elements are detected in the feces of patients, the virus itself is not there, and a fecal-oral route of transmission is impossible. In the lumen of the colon, viruses interacts with the gut microbiota and loses its infectivity. Perhaps it penetrates into the bacteria in the form of bacteriophages. We suggest using the virus’s tropism to intestinal cells to form immune defenses. The formation of immunity and immune memory occurs at the level of the ileum in Peyer’s plaques. If you inject a vaccine (RNA or attenuated live SARS-CoV-2) through the mouth into the small intestine, you can induce the development of intestinal symptoms and the formation of long-term immunity.

Keywords: New Coronavirus Infection COVID-19; SARS-Cov-2 Vaccine; Intestinal Microbiome; Immunity

References

  1. Zhu N., et al. “A novel coronavirus from patients with pneumonia in China, 2019”. The New England Journal of Medicine 382 (2020): 727-733.
  2. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. The Lancet 395 (2020): 497-506.
  3. Redd WD., et al. “Prevalence and characteristics of gastrointestinal symptoms in patients with SARS-CoV-2 infection in the United States: a multicenter cohort study”. Gastroenterology (2020).
  4. Li Q., et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia”. The New England Journal of Medicine 382 (2020): 1199-1207.
  5. Rothe C., et al. “Transmission of 2019-nCoV infection from an asymptomatic contact in Germany”. The New England Journal of Medicine 382 (2020): 970-971.
  6. Peck-Radosavljevic M., et al. “COVID-19 and digestive health”. United European Gastroenterology Journal5 (2020): 624-626.
  7. Cheung KS., et al. “Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis”. Gastroenterology (2020).
  8. Holshue ML., et al. “First case of 2019 novel coronavirus in the United States”. The New England Journal of Medicine 382 (2020): 929-936.
  9. Gu J., et al. “COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission”. Gastroenterology (2020).
  10. Lin L., et al. “Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection”. Gut6 (2020): 997-1001.
  11. Guo YR., et al. “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status”. Military Medical Research 7 (2020): 11.
  12. Zou X., et al. “Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection”. Frontiers in Medicine (2020).
  13. Zhang H., et al. “The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on single-cell transcriptomes”. Bio Rxiv (2020).
  14. Xu H., et al. “High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa”. International Journal of Oral Science 12 (2020): 8.
  15. Schmulson M., et al. “Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19”. Revista de Gastroenterología de México (2020).
  16. Han C., et al. “Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes”. The American Journal of Gastroenterology (2020).
  17. Young BE., et al. “Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore”. JAMA: The Journal of the American Medical Association (2020).
  18. Zhang J., et al. “Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia”. Journal of Medical Virology (2020).
  19. Xiao F., et al. “Evidence for gastrointestinal infection of SARS-CoV-2”. Gastroenterology (2020).
  20. Sethuraman N., et al. “Interpreting Diagnostic Tests for SARS-CoV-2”. JAMA: The Journal of the American Medical Association (2020).
  21. Wang X., et al. “Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved”. International Journal of Infectious Diseases (2020).
  22. Xiao F., et al. “Evidence for gastrointestinal infection of SARS-CoV-2”. Gastroenterology 158 (2020): 1831-1833.
  23. Lerner A. “Covid-19 and the human gut: a new runner on the tract”. International Journal of Celiac Disease2 (2020).
  24. Mills S., et al. “Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota”. Gut Microbes 4 (2013): 4-16.
  25. Stephen AM and Cummings JH. “The microbial contribution to human faecal mass”. Journal of Medical Microbiology 13 (1980): 45-56.
  26. Manrique P., et al. “The human gut phage community and its implications for health and disease”. Viruses 9 (2017): 141.
  27. Navarro F and Muniesa M. “Phages in the human body”. Frontiers in Microbiology 8 (2017): 566.
  28. Zang R., et al. “TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes”. Science Immunology47 (2020): eabc3582.
  29. Wan Y., et al. “Molecular mechanism for antibody-dependent enhancement of coronavirus entry”. Journal of Virology5 (2020).
  30. Gu J and Taylor CR. “Acute immunodeficiency, multiple organ injury, and the pathogenesis of SARS”. Applied Immunohistochemistry Molecular Morphology4 (2003): 281-282.
  31. Gu J., et al. “Multiple organ infection and the pathogenesis of SARS”. Journal of Experimental Medicine3 (2005): 415-424.
  32. Zhao J., et al. “Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019”. Clinical Infectious Diseases (2020).
  33. Wu F., et al. “Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications”. Me Rxiv (2020).
  34. Liu L., et al. “Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection”. JCI Insight4 (2019).
  35. Perlman S and Dandekar AA. “Immunopathogenesis of coronavirus infections: implications for SARS”. Nature Reviews Immunology12 (2005): 917-927.
  36. Tseng CT., et al. “Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus”. PLoS One4 (2012): e35421.
  37. Agrawal AS., et al. “Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus”. Human Vaccines and Immunotherapeutics9 (2016): 2351-2356.
  38. Iwasaki A and Yang Y. “The potential danger of suboptimal antibody responses in COVID-19”. Nature Reviews Immunology (2020).
  39. Alavi Darazam I., et al. “Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial”. Scientific Reports 11 (2021): 8059.
  40. Khan J. “We've never made a successful vaccine for a coronavirus before”. This is why it's so difficult (2020).
Citation: Igor E Khoroshilov. “The Role of the Gut Microbiome in Defense against COVID-19”. EC Gastroenterology and Digestive System 8.11 (2021): 108-114.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.